Bioalpha Holdings Bhd (0179) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bioalpha Holdings Bhd (0179) has a cash flow conversion efficiency ratio of -0.084x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM-5.83 Million ≈ $-1.46 Million USD) by net assets (RM69.43 Million ≈ $17.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Bioalpha Holdings Bhd market cap and net worth for the company's overall valuation and market capitalisation.
Bioalpha Holdings Bhd - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Bioalpha Holdings Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Bioalpha Holdings Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioalpha Holdings Bhd ranked by their cash flow conversion efficiency. Explore Bioalpha Holdings Bhd earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MOVIE GAMES S.A. ZY1
F:2LH
|
0.070x |
|
Champion Bear Resources Ltd.
V:CBA
|
-0.023x |
|
Enterprise Metals Ltd
AU:ENT
|
-0.065x |
|
HELIX Resources Ltd
AU:HLX
|
-0.027x |
|
AIOS Tech Inc.
NASDAQ:AIOS
|
-0.250x |
|
Sare Holding S.A.B. de C.V
MX:SAREB
|
0.015x |
|
Oblong Inc
NASDAQ:OBLG
|
-0.158x |
|
B90 HOLDINGS PLC
F:24GN
|
N/A |
Annual Cash Flow Conversion Efficiency for Bioalpha Holdings Bhd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Bioalpha Holdings Bhd from 2015 to 2025. View Bioalpha Holdings Bhd stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | RM69.43 Million ≈ $17.43 Million |
RM-11.66 Million ≈ $-2.93 Million |
-0.168x | -18666.67% |
| 2024-12-31 | RM98.34 Million ≈ $24.69 Million |
RM88.94K ≈ $22.33K |
0.001x | -95.28% |
| 2023-12-31 | RM127.37 Million ≈ $31.98 Million |
RM2.44 Million ≈ $612.64K |
0.019x | +159.94% |
| 2022-12-31 | RM167.86 Million ≈ $42.14 Million |
RM-5.37 Million ≈ $-1.35 Million |
-0.032x | -60.95% |
| 2021-12-31 | RM186.67 Million ≈ $46.87 Million |
RM-3.71 Million ≈ $-930.73K |
-0.020x | -94.82% |
| 2020-12-31 | RM160.90 Million ≈ $40.40 Million |
RM-1.64 Million ≈ $-411.77K |
-0.010x | -110.37% |
| 2019-12-31 | RM165.55 Million ≈ $41.56 Million |
RM16.27 Million ≈ $4.08 Million |
0.098x | -24.50% |
| 2018-12-31 | RM157.62 Million ≈ $39.57 Million |
RM20.51 Million ≈ $5.15 Million |
0.130x | -56.34% |
| 2017-12-31 | RM135.44 Million ≈ $34.00 Million |
RM40.37 Million ≈ $10.14 Million |
0.298x | +875.06% |
| 2016-12-31 | RM97.99 Million ≈ $24.60 Million |
RM3.00 Million ≈ $752.05K |
0.031x | -54.27% |
| 2015-12-31 | RM79.00 Million ≈ $19.84 Million |
RM5.28 Million ≈ $1.33 Million |
0.067x | -- |
About Bioalpha Holdings Bhd
Bioalpha Holdings Berhad, an investment holding company, manufactures and sells health supplement products in Malaysia, China, and internationally. It operates through Trading and Manufacturing segments. The company also engages in the provision of advertising and promotion services for health supplements, nutrition products, personal care, functional food, and healthcare products; import, export… Read more